Ardent Health (ARDT)


Market Price (11/18/2026): $15.02 | Market Cap: $2.1 BilSector: Health Care | Industry: Health Care Facilities

Ardent Health (ARDT)


Market Price (11/18/2026): $15.02
Market Cap: $2.1 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.9%, FCF Yield is 11%

Low stock price volatility
Vol 12M is 49%

Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Oncology Treatments, Show more.

Trading close to highs
Dist 52W High is -2.4%

Weak multi-year price returns
2Y Excs Rtn is -20%, 3Y Excs Rtn is -57%

Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 60%

Stock price has recently run up significantly
12M Rtn12 month market price return is 114%

Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 78%

Key risks
ARDT key risks include [1] significant adverse accounting adjustments to revenue and liability reserves, Show more.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.9%, FCF Yield is 11%
1 Low stock price volatility
Vol 12M is 49%
2 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Oncology Treatments, Show more.
3 Trading close to highs
Dist 52W High is -2.4%
4 Weak multi-year price returns
2Y Excs Rtn is -20%, 3Y Excs Rtn is -57%
5 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 60%
6 Stock price has recently run up significantly
12M Rtn12 month market price return is 114%
7 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 78%
8 Key risks
ARDT key risks include [1] significant adverse accounting adjustments to revenue and liability reserves, Show more.

ARDT in ETFs

Weight = ARDT's share of each fund

VTI0.00%
IWM0.01%
AVUV0.05%
IWN0.03%
SCHA0.01%
VTWO0.01%
DFAS0.00%
SCHB0.00%

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Prices as of 11/17/2026

Nov 6: up 8.8% in one day (S&P 500 up 0.3%)
The stock moved up without company news. The S&P 500 also rose that day.

Up 132.3% from its Jun 3 low to Nov 11 (S&P 500 up 1.2%)
The stock gained significantly, driven by strong third fiscal quarter results and periods without company news. Key drivers included the November 4 Q3 results, leading to a sharp rise on November 5, and a large increase on June 4.

Nov 5: up 22.4% the day after its Nov 4 earnings report (S&P 500 down 4.4%)
The stock rose sharply after Ardent Health reported strong third fiscal quarter results, beating estimates. Revenue rose 3% and net income and diluted EPS increased 290% and 282% respectively.

Show more
Prices as of 11/17/2026

Nov 6: up 8.8% in one day (S&P 500 up 0.3%)
The stock moved up without company news. The S&P 500 also rose that day.

Up 132.3% from its Jun 3 low to Nov 11 (S&P 500 up 1.2%)
The stock gained significantly, driven by strong third fiscal quarter results and periods without company news. Key drivers included the November 4 Q3 results, leading to a sharp rise on November 5, and a large increase on June 4.

Nov 5: up 22.4% the day after its Nov 4 earnings report (S&P 500 down 4.4%)
The stock rose sharply after Ardent Health reported strong third fiscal quarter results, beating estimates. Revenue rose 3% and net income and diluted EPS increased 290% and 282% respectively.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 66.4% change in ARDT stock from 7/31/2026 to 11/17/2026 was primarily driven by a 52.0% change in the company's P/E Multiple.
(LTM values as of)731202611172026Change
Stock Price ($)10.6717.7566.4%
Change Contribution By: 
Total Revenues ($ Mil)6,4296,4540.4%
Net Income Margin (%)2.1%2.3%8.5%
P/E Multiple11.217.152.0%
Shares Outstanding (Mil)1411410.5%
Cumulative Contribution66.4%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2026 to 11/17/2026
ReturnCorrelation
ARDT66.4% 
Market (SPY)-1.7%-24.1%
Sector (XLV)14.4%9.3%

Fundamental Drivers

The 81.9% change in ARDT stock from 4/30/2026 to 11/17/2026 was primarily driven by a 68.0% change in the company's P/E Multiple.
(LTM values as of)430202611172026Change
Stock Price ($)9.7617.7581.9%
Change Contribution By: 
Total Revenues ($ Mil)6,3246,4542.1%
Net Income Margin (%)2.1%2.3%5.5%
P/E Multiple10.217.168.0%
Shares Outstanding (Mil)1411410.5%
Cumulative Contribution81.9%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 11/17/2026
ReturnCorrelation
ARDT81.9% 
Market (SPY)2.4%-10.4%
Sector (XLV)27.9%23.4%

Fundamental Drivers

The 21.9% change in ARDT stock from 10/31/2025 to 11/17/2026 was primarily driven by a 112.8% change in the company's P/E Multiple.
(LTM values as of)1031202511172026Change
Stock Price ($)14.5617.7521.9%
Change Contribution By: 
Total Revenues ($ Mil)6,1996,4544.1%
Net Income Margin (%)4.1%2.3%-44.9%
P/E Multiple8.017.1112.8%
Shares Outstanding (Mil)140141-0.2%
Cumulative Contribution21.9%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 11/17/2026
ReturnCorrelation
ARDT21.9% 
Market (SPY)8.5%11.9%
Sector (XLV)30.6%24.4%

Fundamental Drivers

null
null

Market Drivers

10/31/2023 to 11/17/2026
ReturnCorrelation
ARDT  
Market (SPY)81.6%18.8%
Sector (XLV)56.4%28.2%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
ARDT Return---6%-48%101%11%
Peers Return64%-30%13%12%23%15%104%
S&P 500 Return27%-19%24%23%16%8%97%

Monthly Win Rates [3]
ARDT Win Rate---50%42%64% 
Peers Win Rate65%45%55%55%57%55% 
S&P 500 Win Rate75%42%67%75%67%36% 

Max Drawdowns [4]
ARDT Max Drawdown-----52%-24% 
Peers Max Drawdown-29%-58%-42%-35%-29%-37% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: HCA, THC, UHS, CYH, SGRY.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 11/17/2026 (YTD)

How Low Can It Go

EventARDTS&P 500
2025 US Tariff Shock
  % Loss-20.5%-18.8%
  % Gain to Breakeven25.7%23.1%
  Time to Breakeven17 days79 days

Compare to HCA, THC, UHS, CYH, SGRY

In The Past

Ardent Health's stock fell -20.5% during the 2025 US Tariff Shock. Such a loss loss requires a 25.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventARDTS&P 500
2025 US Tariff Shock
  % Loss-20.5%-18.8%
  % Gain to Breakeven25.7%23.1%
  Time to Breakeven17 days79 days

Compare to HCA, THC, UHS, CYH, SGRY

In The Past

Ardent Health's stock fell -20.5% during the 2025 US Tariff Shock. Such a loss loss requires a 25.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Ardent Health (ARDT)

Ardent Health (ARDT) is a prominent, privately held, for-profit operator of healthcare services in the United States, ranking as the fourth largest based on the number of hospitals. It operates in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The company delivers care through an integrated system comprising 30 acute care hospitals, over 200 sites of care, and a network of more than 1,700 employed or affiliated providers. Ardent focuses on a consumer-centric approach, aiming to optimize patient access and continuity of care throughout their healthcare journey.

Ardent provides a comprehensive range of general and specialty healthcare services, including internal medicine, surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency care. These services are delivered across various inpatient and ambulatory settings, such as hospitals, primary and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers, supplemented by telehealth services. A key differentiator for Ardent is its well-established Joint Venture (JV) model, where it often holds a majority ownership and serves as the day-to-day operator in partnerships with premier academic medical centers, large not-for-profit systems, and community foundations. This model enhances market penetration, expands access points, and strengthens clinical services.

The company leverages an advanced technology platform to drive care coordination, system productivity, and an improved consumer experience, leading to better patient outcomes. Ardent is actively engaged in value-based care initiatives, designing its services to deliver high-quality, cost-effective care that exceeds CMS benchmarks, positioning itself favorably in the evolving healthcare reimbursement landscape. Its growth strategy involves accelerating ambulatory and physician alignment initiatives to expand physical and virtual consumer access points, aiming to capture additional market share and capitalize on the significant and growing healthcare services sector, primarily serving patients in its targeted mid-sized urban markets.

AI Analysis | Feedback

Here are 1-2 brief analogies for Ardent Health (ARDT):

  • A partnership-driven HCA Healthcare (HCA).

  • A regional hospital operator, similar to Tenet Healthcare (THC), that specializes in joint ventures with local health systems.

AI Analysis | Feedback

  • Hospital Services: Operating acute care hospitals that provide comprehensive medical care for surgeries, complex conditions, and injuries.
  • Specialty Medical Care: Delivering a wide array of specialized treatments, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, and urology.
  • Primary Care Services: Providing accessible general medical care through a network of primary care clinics.
  • Ambulatory Surgery Services: Performing surgical procedures in outpatient settings at dedicated ambulatory surgery centers.
  • Urgent Care Services: Offering immediate medical attention for non-life-threatening conditions through urgent care centers.
  • Emergency Services: Providing care for medical emergencies through hospital emergency departments and free-standing emergency departments.
  • Diagnostic Imaging Services: Operating diagnostic imaging centers to provide various medical imaging services.
  • Telehealth Services: Delivering virtual healthcare consultations and services to enhance patient access and convenience.
  • Value-Based Care Programs: Participating in accountable care organizations (ACOs) to offer coordinated, high-quality, and cost-effective patient care.

AI Analysis | Feedback

Ardent Health (ARDT) primarily sells its healthcare services to individuals, referred to as "patients" or "consumers" in the provided description.

The company serves a broad spectrum of the population across various healthcare needs and settings. Based on the services and facilities described, the major categories of customers it serves include:

  1. Patients requiring Acute and Specialty Hospital Care: These are individuals who utilize Ardent's 30 acute care hospitals for general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, often involving complex medical conditions, injuries, or inpatient stays.
  2. Patients accessing Ambulatory and Outpatient Services: This category includes individuals who receive care at Ardent's extensive network of ambulatory facilities, such as primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. These services generally cover routine check-ups, specialized consultations, minor procedures, and urgent non-life-threatening conditions.
  3. Patients utilizing Virtual and Telehealth Services: These are individuals who leverage Ardent's telehealth services and virtual care platforms for remote consultations, follow-ups, and other healthcare needs, emphasizing convenience and accessibility.

AI Analysis | Feedback

null

AI Analysis | Feedback

Marty Bonick, President & Chief Executive Officer

Marty Bonick has been President and CEO of Ardent Health Services since August 2020. He brings nearly 25 years of healthcare leadership experience across for-profit, non-profit, public, and private companies. Prior to joining Ardent, he was CEO of PhyMed Healthcare Group, a national provider of anesthesia and pain management services, where he was instrumental in driving substantial growth organically and through acquisitions. He also held the role of Division President at Community Health Systems, where he led operations for 36 hospitals. Bonick began his career in healthcare at Hillcrest HealthCare System, which was acquired by Ardent during his time there.

Alfred Lumsdaine, Chief Financial Officer

Alfred Lumsdaine has served as Ardent's Chief Financial Officer since 2021, bringing more than 30 years of healthcare finance experience. Previously, he was Executive Vice President and CFO of Quorum Health Corporation from 2018 to 2021, where he oversaw financial operations for 22 acute care hospitals and led a significant financial restructuring. Before Quorum Health, he was President of Population Health for Sharecare and spent five years as CFO for Tivity Health (formerly Healthways) prior to its acquisition by Sharecare. He started his career at Ernst & Young in external audit, focusing on healthcare.

Dave Caspers, Chief Operating Officer

Dave Caspers was appointed Chief Operating Officer in March 2025. In this role, he is responsible for overseeing operations across Ardent Health, executing strategic growth initiatives, and driving operational excellence. Before joining Ardent, Caspers served as vice president of omnichannel operations at Walmart Health.

FJ Campbell, MD, Chief Medical Officer

Dr. FJ Campbell has been with Ardent since 2017. Prior to his time at Ardent, he served as the vice president of chief medical services at Community Health Systems (CHS) from 2014 to 2017. He also held the position of chief medical officer for CareSpot Express Healthcare. Dr. Campbell is a board-certified emergency medicine physician.

Steve Petrovich, Chief Legal Officer

Steve Petrovich has been with Ardent since its formation in 2001, having previously served as general counsel for its predecessor, Behavioral Health Corporation. He also holds the title of Executive Vice President.

AI Analysis | Feedback

  • The company's significant reliance on its joint venture (JV) model poses a key risk. Any changes in these JV relationships could disrupt ongoing business, negatively affect cash flows, and distract management and other key personnel. Furthermore, the interests of JV partners may differ from those of Ardent Health, potentially limiting the company's ability to effectively operate the related JVs and maximize economic benefits, especially considering a significant portion of its revenue and net income is attributable to these JVs and variable interest entities (VIEs).

AI Analysis | Feedback

null

AI Analysis | Feedback

Ardent Health’s serviceable addressable market for hospital, physician, and clinical services, specifically in markets that align with their strategic focus on mid-sized urban communities, approaches $800 billion. This market size is for the U.S. region. The total expenditures for hospital services and physician and clinical services in the United States collectively amounted to over $2.2 trillion in 2022.

AI Analysis | Feedback

Expected Drivers of Future Revenue Growth for Ardent Health (ARDT)

  • Expansion of ambulatory and physician footprint and virtual care access points: Ardent Health is accelerating its ambulatory and physician alignment initiatives to expand both physical and virtual consumer access points, a strategy expected to grow market share and drive performance. The company has already increased its ambulatory and physician footprint significantly, adding more than 95 ambulatory facilities and 850 providers between 2017 and 2023.

  • Expansion into new markets through acquisitions and strategic Joint Ventures (JVs): Growth through acquisitions and JV partnerships has enabled Ardent Health to enter new attractive markets, and the company believes it has significant opportunities to expand into new markets. The well-established JV model is a core differentiator that facilitates enhanced scale and provides unique opportunities to establish new markets and access points.

  • Increased market share capture in current markets: The company holds a leading position in a majority of its markets and believes it has significant opportunities to capture additional market share in these existing markets. Its consumer-centric approach and comprehensive healthcare ecosystem are designed to engage with patients over their lifetime and expand market presence.

  • Leveraging the strategic Joint Venture (JV) model: Ardent Health's differentiated JV model, where it is the majority owner and day-to-day operator in partnerships with premier academic medical centers and not-for-profit health systems, provides significant advantages such as expanded access points, clinical talent availability, local brand recognition, and scale, which accelerate market penetration. This model contributes a substantial portion of the company's revenue and net income.

  • Growth of value-based care initiatives: Ardent Health is focused on its value-based care initiatives, which are designed to deliver high-quality care that exceeds CMS benchmarks in a cost-effective manner for payors. Participation in multiple collaborative accountable care organizations (ACOs) through its provider network positions the company favorably in the evolving healthcare reimbursement landscape, potentially leading to increased patient volumes and optimized revenue streams.

AI Analysis | Feedback

Outbound Investments

  • Ardent Health pursues growth through acquisitions and joint venture (JV) partnerships to enter new attractive markets.
  • The company expanded its ambulatory and physician footprint by adding more than 95 ambulatory facilities and 850 providers between 2017 and 2023.

Capital Expenditures

  • Capital expenditures are primarily focused on accelerating ambulatory and physician alignment initiatives to expand both physical and virtual consumer access points.
  • Investments are also made to leverage an advanced technology platform, aiming to drive enhanced care coordination and system productivity.

Better Bets vs. Ardent Health (ARDT)

Peer Outperformance in Health Care Facilities

null
Share of Health Care Facilities constituents that ARDT has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
1Y
90%
of 30 industry peers · 114.4% return
3Y
—
insufficient peer history
5Y
—
insufficient peer history
null
Median price return by industry across the Health Care sector, ranked by 5Y. Health Care Facilities is ARDT's own industry. Use this to see which corners of the sector have carried the returns.
Industry Names 1Y med3Y med5Y med Top 3 by 5Y
Health Care Distributors 5 16.4%84.2%198.3% CAH 522% · MCK 400% · COR 198%
Health Care Services 20 31.2%20.2%12.4% RDNT 150% · HIMS 116% · DGX 91%
Managed Health Care 8 76.8%-0.8%0.8% OSCR 155% · HQY 56% · ELV 9%
Health Care Facilities ← 26 17.8%19.4%-9.2% THC 258% · NHC 231% · EHC 186%
Health Care Equipment 49 -1.7%4.4%-20.2% GKOS 390% · UFPT 359% · TMDX 293%
Health Care Supplies 11 24.0%1.1%-40.5% LNTH 248% · HAE 108% · MMSI 25%
Pharmaceuticals 60 -18.7%1.7%-45.2% LQDA 1123% · KNSA 638% · XERS 586%
Life Sciences Tools & Services 110 -22.4%-26.1%-76.2% AXGN 400% · MEDP 187% · NTRA 156%
Health Care Technology 23 -23.5%-59.7%-83.4% VEEV -8% · DOCS -55%
Biotechnology 370 -33.7%-38.5%-83.9% ELVN 1378% · TRVI 1175% · DNTH 1141%
Median of constituents with a full price history over each window. Top names are limited to companies above $2B market cap.

Latest Trefis Analyses

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

ARDTHCATHCUHSCYHSGRYMedian
NameArdent H.HCA Heal.Tenet He.Universa.Communit.Surgery . 
Mkt Price15.02500.77282.02191.982.0326.81109.39
Mkt Cap2.1107.522.611.30.33.57.4
Rev LTM6,45478,70123,62618,35311,6533,36015,003
Op Inc LTM33712,0525,3211,9918544341,423
FCF LTM2825,9733,3281,094-122203688
FCF 3Y Avg1806,6502,4081,0005187593
CFO LTM48211,1694,2382,0562112781,269
CFO 3Y Avg37011,5453,3061,9553532701,163

Growth & Margins

ARDTHCATHCUHSCYHSGRYMedian
NameArdent H.HCA Heal.Tenet He.Universa.Communit.Surgery . 
Rev Chg LTM2.0%5.8%13.3%8.0%-7.8%2.2%4.0%
Rev Chg 3Y Avg9.4%7.6%5.6%9.4%-2.1%7.4%7.5%
Rev Chg Q3.1%3.6%18.7%5.3%-10.7%-0.8%3.3%
QoQ Delta Rev Chg LTM0.8%0.9%4.4%1.3%-2.8%-0.2%0.8%
Op Inc Chg LTM-11.0%3.6%59.0%2.2%-21.1%-13.0%-4.4%
Op Inc Chg 3Y Avg9.6%9.3%32.8%22.7%2.1%4.8%9.5%
Op Mgn LTM5.2%15.3%22.5%10.8%7.3%12.9%11.9%
Op Mgn 3Y Avg5.3%15.3%17.4%10.8%7.4%14.3%12.5%
QoQ Delta Op Mgn LTM1.2%-0.2%3.0%-0.5%-0.7%-0.8%-0.3%
CFO/Rev LTM7.5%14.2%17.9%11.2%1.8%8.3%9.7%
CFO/Rev 3Y Avg6.0%15.6%15.0%11.6%2.8%8.4%10.0%
FCF/Rev LTM4.4%7.6%14.1%6.0%-1.0%6.0%6.0%
FCF/Rev 3Y Avg2.9%9.0%10.9%5.9%0.0%5.8%5.9%

Valuation

ARDTHCATHCUHSCYHSGRYMedian
NameArdent H.HCA Heal.Tenet He.Universa.Communit.Surgery . 
Mkt Cap2.1107.522.611.30.33.57.4
P/S0.31.41.00.60.01.00.8
P/Op Inc6.38.94.25.70.38.06.0
P/EBIT6.18.84.15.30.29.55.7
P/E14.415.97.87.77.6-39.77.8
P/CFO4.49.65.35.51.312.45.4
Total Yield5.9%6.9%12.8%13.4%13.1%-2.5%9.9%
Dividend Yield0.0%0.6%0.0%0.4%0.0%0.0%0.0%
FCF Yield 3Y Avg10.6%6.8%13.2%8.1%0.3%7.5%7.8%
D/E1.10.50.60.537.11.00.8
Net D/E0.70.50.50.536.50.90.6

Returns

ARDTHCATHCUHSCYHSGRYMedian
NameArdent H.HCA Heal.Tenet He.Universa.Communit.Surgery . 
1M Rtn25.7%9.1%5.5%3.7%-29.5%83.5%7.3%
3M Rtn37.4%21.9%4.4%11.0%-31.9%88.3%16.4%
6M Rtn53.3%24.2%47.3%15.6%-27.5%95.8%35.8%
12M Rtn81.4%5.7%46.6%-14.9%-32.6%78.0%26.1%
3Y Rtn-6.5%108.0%342.5%43.1%-27.5%-16.8%18.3%
1M Excs Rtn31.5%13.6%9.4%8.9%-22.9%85.8%11.5%
3M Excs Rtn44.6%27.0%8.8%15.3%-26.7%100.9%21.2%
6M Excs Rtn52.5%23.4%46.5%14.8%-28.4%95.0%34.9%
12M Excs Rtn58.1%-3.5%36.1%-24.5%-47.9%65.3%16.3%
3Y Excs Rtn-64.0%52.1%356.3%-18.6%-82.3%-65.5%-41.3%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil202520242023
Other managed care2,8002,6002,305
Medicare2,4402,3342,137
Medicaid605613607
Self-pay and other360313268
Other revenue11910793
Total6,3245,9665,409


Price Behavior

Price Behavior
Market Price$17.75 
Market Cap ($ Bil)2.5 
First Trading Date07/18/2024 
Distance from 52W High-2.4% 
   50 Days200 Days
DMA Price$12.43$10.45
DMA Trendupup
Distance from DMA42.8%69.8%
 3M1YR
Volatility59.8%49.3%
Downside Capture-98.6944.11
Upside Capture164.29120.05
Correlation (S&P 500)-26.2%7.1%
ARDT Betas & Captures as of 10/31/2026

 1M2M3M6M1Y3Y
Beta0.170.300.210.271.040.00
Up Beta-0.60-0.21-0.00-0.410.290.07
Down Beta1.801.090.961.341.98-0.36
Up Capture92%52%35%27%78%16%
Bmk +ve Days12182862130427
Stock +ve Days14243264124285
Down Capture-154%-37%-36%-15%115%88%
Bmk -ve Days10253664121325
Stock -ve Days8193159121277

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ARDT
ARDT97.5%49.3%1.53-
Sector ETF (XLV)24.2%16.9%1.1029.2%
Equity (SPY)10.2%13.8%0.456.9%
Gold (GLD)-6.3%28.8%-0.2311.6%
Commodities (DBC)31.6%21.3%1.18-21.5%
Real Estate (VNQ)10.0%14.2%0.4225.2%
Bitcoin (BTCUSD)-31.4%43.7%-0.757.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ARDT
ARDT2.2%53.5%0.29-
Sector ETF (XLV)8.6%15.4%0.3628.2%
Equity (SPY)10.9%17.3%0.4618.8%
Gold (GLD)15.5%19.2%0.655.8%
Commodities (DBC)7.1%19.6%0.25-7.0%
Real Estate (VNQ)0.9%19.0%-0.0626.7%
Bitcoin (BTCUSD)-0.6%51.4%0.176.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ARDT
ARDT1.1%53.5%0.29-
Sector ETF (XLV)12.4%16.8%0.6128.2%
Equity (SPY)14.9%18.0%0.7018.8%
Gold (GLD)11.2%16.6%0.555.8%
Commodities (DBC)7.4%18.2%0.32-7.0%
Real Estate (VNQ)5.8%20.7%0.2426.7%
Bitcoin (BTCUSD)57.2%66.3%0.976.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date10302026
Short Interest: Shares Quantity3.4 Mil
Short Interest: % Change Since 10152026-8.2%
Average Daily Volume0.4 Mil
Days-to-Cover Short Interest8.8 days
Basic Shares Quantity140.6 Mil
Short % of Basic Shares2.5%

Earnings Returns History

Updated 11/13/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/4/202622.4%40.0% 
8/4/20263.8%2.0%1.5%
5/5/2026-7.5%-0.6%-15.1%
3/4/2026-2.1%-6.4%-10.2%
11/12/2025-33.8%-38.6%-36.7%
8/5/20256.1%17.1%20.8%
5/6/20259.2%11.6%13.4%
2/26/20258.2%9.4%-6.1%
...
SUMMARY STATS   
# Positive775
# Negative334
Median Positive7.8%9.4%13.4%
Median Negative-7.5%-6.4%-12.6%
Max Positive22.4%40.0%20.8%
Max Negative-33.8%-38.6%-36.7%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/4/202622.4%40.0% 
8/4/20263.8%2.0%1.5%
5/5/2026-7.5%-0.6%-15.1%
3/4/2026-2.1%-6.4%-10.2%
11/12/2025-33.8%-38.6%-36.7%
8/5/20256.1%17.1%20.8%
5/6/20259.2%11.6%13.4%
2/26/20258.2%9.4%-6.1%
11/6/20247.8%4.5%2.3%
8/14/20246.1%5.7%13.4%
SUMMARY STATS   
# Positive775
# Negative334
Median Positive7.8%9.4%13.4%
Median Negative-7.5%-6.4%-12.6%
Max Positive22.4%40.0%20.8%
Max Negative-33.8%-38.6%-36.7%

SEC Filings

Expand for More
Report DateFiling DateFiling
09/30/202611/05/202610-Q
06/30/202608/10/202610-Q
03/31/202605/06/202610-Q
12/31/202503/16/202610-K
09/30/202511/14/202510-Q
06/30/202508/06/202510-Q
03/31/202505/07/202510-Q
12/31/202402/27/202510-K
09/30/202411/07/202410-Q
06/30/202408/14/202410-Q
03/31/202407/18/2024424B4
12/31/201803/06/2019S-1/A
09/30/201812/21/2018S-1/A
Collapse to Preview
Report DateFiling DateFiling
09/30/202611/05/202610-Q
06/30/202608/10/202610-Q
03/31/202605/06/202610-Q
12/31/202503/16/202610-K
09/30/202511/14/202510-Q
06/30/202508/06/202510-Q
03/31/202505/07/202510-Q
12/31/202402/27/202510-K
09/30/202411/07/202410-Q
06/30/202408/14/202410-Q
03/31/202407/18/2024424B4
12/31/201803/06/2019S-1/A
09/30/201812/21/2018S-1/A

Recent Forward Guidance

Updated 11/5/2026

Latest: Q3 2026 Earnings Reported 11/4/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2026 Rent expense payable to REITsReported 168.00 Mil    
2026 Adjusted admissions growthReported1.5%2.0%2.5% 0.0%AffirmedGuidance: 2.0% for 2026
2026 IMPACT Program SavingsReported70.00 Mil70.00 Mil 0.0% AffirmedGuidance: 70.00 Mil for 2026
2026 Total revenueReported6.40 Bil6.55 Bil6.70 Bil0.0% AffirmedGuidance: 6.55 Bil for 2026
2026 Adjusted EBITDAReported500.00 Mil517.50 Mil535.00 Mil1.5% RaisedGuidance: 510.00 Mil for 2026
2026 Net income attributable to Ardent Health, Inc.Reported132.00 Mil149.50 Mil167.00 Mil9.5% RaisedGuidance: 136.50 Mil for 2026
2026 Net incomeReported209.00 Mil231.50 Mil254.00 Mil   
2026 Diluted earnings per shareReported0.931.061.189.3% RaisedGuidance: 0.97 for 2026
2026 Capital expendituresReported210.00 Mil230.00 Mil250.00 Mil-6.1% LoweredGuidance: 245.00 Mil for 2026


Prior: Q2 2026 Earnings Reported 8/4/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2026 Adjusted admissions growthReported1.5%2.0%2.5% 0AffirmedGuidance: 2.0% for 2026
2026 IMPACT program savingsReported 70.00 Mil    
2026 Total RevenueReported6.40 Bil6.55 Bil6.70 Bil0 AffirmedGuidance: 6.55 Bil for 2026
2026 Adjusted EBITDAReported485.00 Mil510.00 Mil535.00 Mil0 AffirmedGuidance: 510.00 Mil for 2026
2026 Net Income Attributable to Ardent Health, Inc.Reported110.00 Mil136.50 Mil163.00 Mil-12.5% LoweredGuidance: 156.00 Mil for 2026
2026 Diluted earnings per shareReported0.780.971.15-11.1% LoweredGuidance: 1.09 for 2026
2026 Capital expendituresReported225.00 Mil245.00 Mil265.00 Mil0 AffirmedGuidance: 245.00 Mil for 2026

Q1 2026 Earnings Reported 5/5/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2026 Adjusted admissions growthReported1.5%2.0%2.5% 0AffirmedGuidance: 2.0% for 2026
2026 Total RevenueReported6.40 Bil6.55 Bil6.70 Bil0 AffirmedGuidance: 6.55 Bil for 2026
2026 Adjusted EBITDAReported485.00 Mil510.00 Mil535.00 Mil0 AffirmedGuidance: 510.00 Mil for 2026
2026 Net income attributable to Ardent Health, Inc.Reported129.00 Mil156.00 Mil183.00 Mil0 AffirmedGuidance: 156.00 Mil for 2026
2026 Diluted earnings per shareReported0.91.091.270 AffirmedGuidance: 1.09 for 2026
2026 Capital expendituresReported225.00 Mil245.00 Mil265.00 Mil0 AffirmedGuidance: 245.00 Mil for 2026

Q4 2025 Earnings Reported 3/4/2026

Forward GuidanceGuidance Change
MetricSourceLowMidHigh% Chg% DeltaChangePrior
2026 Adjusted admissions growthReported1.5%2.0%2.5% -0.5%Lower NewGuidance: 2.5% for 2025
2026 Total RevenueReported6.40 Bil6.55 Bil6.70 Bil3.6% Higher NewGuidance: 6.33 Bil for 2025
2026 Adjusted EBITDAReported485.00 Mil510.00 Mil535.00 Mil-6.0% Lower NewGuidance: 542.50 Mil for 2025
2026 Net IncomeReported129.00 Mil156.00 Mil183.00 Mil16.9% Higher NewGuidance: 133.50 Mil for 2025
2026 Diluted earnings per shareReported0.91.091.2715.4% Higher NewGuidance: 0.94 for 2025
2026 Capital expendituresReported225.00 Mil245.00 Mil265.00 Mil8.9% Higher NewGuidance: 225.00 Mil for 2025

Insider Activity

Updated 6/8/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Demichiei, Robert DirectBuy60820268.7311,26098,300310,474Form
2Lumsdaine, AlfredChief Financial OfficerDirectBuy60820268.8110,00088,1002,900,102Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Demichiei, Robert DirectBuy60820268.7311,26098,300310,474Form
2Lumsdaine, AlfredChief Financial OfficerDirectBuy60820268.8110,00088,1002,900,102Form

Investor Activity (13F)

Updated Nov 18, 2026
13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Chai Trust Co LLC$661.2 Mil56.0%12Hold13F
Goldentree Asset Management LP$19.7 Mil1.2%29Hold13F
Active Manager
Active Manager
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Chai Trust Co LLC$661.2 Mil56.0%12Hold13F
Goldentree Asset Management LP$19.7 Mil1.2%29Hold13F
Core Cache Last Updated: 11/17/2026